JNJ vs WPC · P/E 17, rev $49.37B vs P/E 44, rev $915.6M
Johnson & Johnson (JNJ) versus W P Carey Inc (WPC) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
W P Carey Inc (WPC) is a reit - diversified company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported WPC revenue for 2026-06-30 was $915.6M. Net income was $361.7M. WPC currently screens at market cap $14.69B and trailing P/E 44.1.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. WPC currently screens at market cap $14.69B and trailing P/E 44.1.
Not investment advice. Open the JNJ and WPC stock pages for the full models.
Not investment advice.